Alkyl modified chitosan/mesoporous silicon dioxide composite quick hemostatic powder and preparation method thereof

A technology of mesoporous silica and alkyl modification, which is applied in medical science, bandages, absorbent pads, etc., can solve the problems of biological safety hazards, unfavorable hemostasis control, low gel strength, etc., and achieve no side effects, biological Good compatibility with tissue and excellent hemostatic effect

Inactive Publication Date: 2012-11-14
SANITARY EQUIP INST ACAD OF MILITARY MEDICAL SCI PLA
View PDF4 Cites 34 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Hudson et al. studied the biosafety of mesoporous silicon particles with different particle sizes and pore sizes in subcutaneous, intraperitoneal and intravenous, and the results showed that although the local tissue reaction of mesoporous silicon particles is benign, they enter blood vessels and tissues and organs. Mesoporous silica particles can cause severe systemic toxicity
[0007] The inventors of the present application believe that the alkyl modified chitos...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Alkyl modified chitosan/mesoporous silicon dioxide composite quick hemostatic powder and preparation method thereof
  • Alkyl modified chitosan/mesoporous silicon dioxide composite quick hemostatic powder and preparation method thereof
  • Alkyl modified chitosan/mesoporous silicon dioxide composite quick hemostatic powder and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] A preparation method of alkyl-modified chitosan / mesoporous silica composite rapid hemostatic powder includes the following steps:

[0023] (1) Preparation of alkyl-modified chitosan: According to the proportion, add 4g of chitosan with an average molecular weight of 300K and a degree of deacetylation of 85% to 200ml of acetic acid aqueous solution with a volume concentration of 1%. After it is completely dissolved, add Blend with 150ml of ethanol, adjust the pH to 5 with 1M sodium hydroxide aqueous solution, add 10ml of 25mg / ml p-octadecylbenzaldehyde ethanol solution, then add 5mg of sodium cyanoborohydride, and stir at room temperature for 24 hours. Adjust the pH to 7 with 1M sodium hydroxide aqueous solution, add 200ml ethanol for precipitation, centrifuge, the precipitate is washed with 70%, 85%, ethanol and ethanol, and freeze-dried to obtain alkyl-modified chitosan;

[0024] figure 1 It is the ultraviolet-visible light absorption spectrum of alkyl-modified chitosan. It...

Embodiment 2

[0030] A preparation method of alkyl-modified chitosan / mesoporous silica composite rapid hemostatic powder includes the following steps:

[0031] Preparation of alkyl-modified chitosan: According to the ratio, 4g of chitosan with an average molecular weight of 200K and a degree of deacetylation of 75% was added to 200ml of 1% acetic acid aqueous solution. After it was completely dissolved, 150ml of ethanol was added. Mix, adjust the pH to 5 with 1M sodium hydroxide aqueous solution, add 10ml of 25mg / ml p-octadecylbenzaldehyde ethanol solution, and then add 5mg sodium cyanoborohydride, stir at room temperature for 24 hours, and use hydroxide Adjust the pH value of the sodium aqueous solution to 7, add 200ml ethanol for precipitation, centrifuge, the precipitate is washed with 70%, 85% ethanol aqueous solution and ethanol successively, and freeze-dried to obtain alkyl modified chitosan;

[0032] 2) Preparation of mesoporous silica particles: 200ml of tetraethyl orthosilicate, 100ml o...

Embodiment 3

[0035] A preparation method of alkyl-modified chitosan / mesoporous silica composite rapid hemostatic powder includes the following steps:

[0036] (1) Preparation of alkyl-modified chitosan: add 4g of chitosan with an average molecular weight of 150K and a degree of deacetylation of 85% to 200ml of acetic acid aqueous solution with a volume concentration of 1% according to the proportions. After it is completely dissolved, add Blend with 150ml of ethanol, adjust the pH to 5 with 1M sodium hydroxide aqueous solution, add 10ml of 25mg / ml p-octadecylbenzaldehyde ethanol solution, then add 5mg of sodium cyanoborohydride, and stir at room temperature for 24 hours. Adjust the pH to 7 with 1M sodium hydroxide aqueous solution, add 200ml ethanol for precipitation, centrifuge, the precipitate is washed with 70%, 85%, ethanol and ethanol, and freeze-dried to obtain alkyl-modified chitosan;

[0037] 2) Preparation of mesoporous silica particles: 200ml of tetraethyl orthosilicate, 100ml of etha...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Average molecular weightaaaaaaaaaa
Average molecular weightaaaaaaaaaa
Login to view more

Abstract

The invention discloses an alkyl modified chitosan/mesoporous silicon dioxide composite quick hemostatic powder and a preparation method thereof. The method comprises the following steps: 1) preparation of alkyl modified chitosan; 2) preparation of mesoporous silicon dioxide particles; and 3) preparation of composite quick hemostatic powder: dissolving the alkyl modified chitosan in an acetic acid water solution, adding polyethyleneglycol 20000 to be dissolved, adding the mesoporous silicon dioxide particles prepared in the step 2), stirring at room temperature, freeze-drying the precipitate, suspending the precipitate in dimethylsulfoxide, regulating the pH value, centrifuging, washing with deionized water, and freeze-drying to obtain the alkyl modified chitosan/mesoporous silicon dioxide composite quick hemostatic powder. The hemostatic powder disclosed by the invention can quickly stop bleeding, and is suitable for pre-hospital emergency treatment of severe bleeding wounded persons. The material has the advantages of high hemostatic speed, excellent hemostatic effect, favorable biocompatibility and histocompatibility, and no side effect.

Description

Technical field [0001] The invention relates to a hemostatic material and a preparation method, in particular to an alkyl-modified chitosan / mesoporous silica composite rapid hemostatic powder and a preparation method thereof. Background technique [0002] Bleeding from trauma is one of the most common injuries at the scene of various accidents on the battlefield and peacetime. Loss of control of bleeding is the leading cause of death at the scene and serious complications (such as amputation). Therefore, it is of great significance to effectively control the bleeding of the wounded at the scene and before the hospital. Tourniquets are life-saving equipment that can control bleeding, but many parts of the human body, such as the chest, abdomen, head, and neck, cannot be used. Traditional hemostatic materials (such as cotton yarn, bandages) have poor hemostatic effects for common wounds such as irregular shapes, deep, narrow, and arterial ruptures. Therefore, the development of f...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61L15/28A61L15/18A61L15/44A61L15/42
Inventor 李钒刘长军田丰杨健张彦军杜振杰孙秋明
Owner SANITARY EQUIP INST ACAD OF MILITARY MEDICAL SCI PLA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products